Oral supplementation with a combination of L-citrulline and L-arginine rapidly increases plasma L-arginine concentration and enhances NO bioavailability

Biochemical and Biophysical Research Communications

Volumn 454, Issue 1, 2014, Pages 53-57

  Morita, Masahiko ^a   Hayashi, Toshio ^b   Ochiai, Masayuki ^a   Maeda, Morihiko ^b   Yamaguchi, Tomoe ^b   Ina, Koichiro ^b   Kuzuya, Masafumi ^b  

^a Kyowa Hakko Bio Co   (Japan)

^b NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Blood circulation; Cyclic GMP; L Arginine; L Citrulline; Nitric oxide

Indexed keywords

ARGININE; CITRULLINE; CYCLIC GMP; NITRIC OXIDE;

AMINO ACID BLOOD LEVEL; ANIMAL EXPERIMENT; ARTERY BLOOD FLOW; ARTICLE; BIOAVAILABILITY; CIRCULATION; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; EAR ARTERY; MALE; NEW ZEALAND WHITE (RABBIT); NONHUMAN; PROTEIN BLOOD LEVEL; RAT; SINGLE DRUG DOSE; TREATMENT OUTCOME; ANIMAL; ATHEROSCLEROSIS; BLOOD; DIET SUPPLEMENTATION; DRUG EFFECTS; DRUG POTENTIATION; HUMAN; ORAL DRUG ADMINISTRATION; RABBIT; SIGNAL TRANSDUCTION; SPRAGUE DAWLEY RAT;

ADMINISTRATION, ORAL; ANIMALS; ARGININE; ATHEROSCLEROSIS; BIOLOGICAL AVAILABILITY; CITRULLINE; CYCLIC GMP; DIETARY SUPPLEMENTS; DRUG SYNERGISM; HUMANS; MALE; NITRIC OXIDE; RABBITS; RATS; RATS, SPRAGUE-DAWLEY; SIGNAL TRANSDUCTION;

EID: 84910658086     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2014.10.029     Document Type: Article

References (36)

1. L.J. Ignarro, C. Napoli, Novel features of nitric oxide, endothelial nitric oxide synthase, and atherosclerosis, Curr. Atheroscler. Rep. 6 (2004) 281-287.
2. M. Mori, T. Gotoh, Regulation of nitric oxide production by arginine metabolic enzymes, Biochem. Biophys. Res. Commun. 275 (2000) 715-719.
3. S. Moncada, J.P. Bolanos, Nitric oxide, cell bioenergetics and neurodegeneration, J. Neurochem. 97 (2006) 1676-1689.
4. P. Kubes, M. Suzuki, D.N. Granger, Nitric oxide: an endogenous modulator of leukocyte adhesion, Proc. Natl. Acad. Sci. U.S.A. 88 (1991) 4651-4655.
5. L.J. Ignarro, G.M. Buga, L.H. Wei, et al., Role of the arginine-nitric oxide pathway in the regulation of vascular smooth muscle cell proliferation, Proc. Natl. Acad. Sci. U.S.A. 98 (2001) 4202-4208.
6. C. Napoli, E. Ackah, F. De Nigris, et al., Chronic treatment with nitric oxide-releasing aspirin reduces plasma low-density lipoprotein oxidation and oxidative stress, arterial oxidation-specific epitopes, and atherogenesis in hypercholesterolemic mice, Proc. Natl. Acad. Sci. U.S.A. 99 (2002) 12467-12470.
7. R.O. Cannon 3rd, Role of nitric oxide in cardiovascular disease: focus on the endothelium, Clin. Chem. 44 (1998) 1809-1819.
8. M.M. Elahi, K.M. Naseem, B.M. Matata, Nitric oxide in blood. The nitrosative-oxidative disequilibrium hypothesis on the pathogenesis of cardiovascular disease, FEBS J. 274 (2007) 906-923.
9. W. Aji, S. Ravalli, M. Szabolcs, et al., L-arginine prevents xanthoma development and inhibits atherosclerosis in LDL receptor knockout mice, Circulation 95 (1997) 430-437.
10. A.A. El-Kirsh, H.M. Abd El-Wahab, H.F. Abd-Ellah Sayed, The effect of L-arginine or L-citrulline supplementation on biochemical parameters and the vascular aortic wall in high-fat and high-cholesterol-fed rats, Cell Biochem. Funct. 29 (2011) 414-428.
11. W.J. Fu, T.E. Haynes, R. Kohli, et al., Dietary L-arginine supplementation reduces fat mass in Zucker diabetic fatty rats, J. Nutr. 135 (2005) 714-721.
12. G. Siasos, D. Tousoulis, C. Vlachopoulos, et al., Short-term treatment with L-arginine prevents the smoking-induced impairment of endothelial function and vascular elastic properties in young individuals, Int. J. Cardiol. 126 (2008) 394-399.
13. C.C. Lin, W.C. Tsai, J.Y. Chen, et al., Supplements of L-arginine attenuate the effects of high-fat meal on endothelial function and oxidative stress, Int. J. Cardiol. 127 (2008) 337-341.
14. S.M. Bode-Boger, J. Muke, A. Surdacki, et al., Oral L-arginine improves endothelial function in healthy individuals older than 70 years, Vasc. Med. 8 (2003) 77-81.
15. R.H. Boger, L.M. Sullivan, E. Schwedhelm, et al., Plasma asymmetric dimethylarginine and incidence of cardiovascular disease and death in the community, Circulation 119 (2009) 1592-1600.
16. E. Schwedhelm, R. Maas, R. Freese, et al., Pharmacokinetic and pharmacodynamic properties of oral L-citrulline and L-arginine: impact on nitric oxide metabolism, Br. J. Clin. Pharmacol. 65 (2008) 51-59.
17. M. Ochiai, T. Hayashi, M. Morita, et al., Short-term effects of L-citrulline supplementation on arterial stiffness in middle-aged men, Int. J. Cardiol. 155 (2012) 257-261.
18. M. Morita, M. Sakurada, F. Watanabe, et al., Effects of oral L-citrulline supplementation on lipoprotein oxidation and endothelial dysfunction in humans with vasospastic angina, Immunol. Endocr. Metab. Agents Med. Chem. 13 (2013) 214-220.
19. A. Figueroa, M.A. Sanchez-Gonzalez, A. Wong, et al., Watermelon extract supplementation reduces ankle blood pressure and carotid augmentation index in obese adults with prehypertension or hypertension, Am. J. Hypertens. 25 (2012) 640-643.
20. N. Kameda, T. Okigawa, T. Kimura, et al., The effect of L-citrulline ingestion on ECG QT interval and autonomic nervous system activity, J. Physiol. Anthropol. 30 (2011) 41-45.
21. T. Hayashi, P.A. Juliet, H. Matsui-Hirai, et al., L-citrulline and L-arginine supplementation retards the progression of high-cholesterol-diet-induced atherosclerosis in rabbits, Proc. Natl. Acad. Sci. U.S.A. 102 (2005) 13681-13686.
22. C. Moinard, I. Nicolis, N. Neveux, et al., Dose-ranging effects of citrulline administration on plasma amino acids and hormonal patterns in healthy subjects: the Citrudose pharmacokinetic study, Br. J. Nutr. 99 (2008) 855-862.
23. T. Hayashi, T. Esaki, E. Muto, et al., Dehydroepiandrosterone retards atherosclerosis formation through its conversion to estrogen: the possible role of nitric oxide, Arterioscler. Thromb. Vasc. Biol. 20 (2000) 782-792.\
24. K. Okano, S. Takahashi, K. Yasuda, et al., Using microparticle labeling and counting for attomole-level detection in heterogeneous immunoassay, Anal. Biochem. 202 (1992) 120-125.
25. A. Lerman, J.C. Burnett Jr., S.T. Higano, et al., Long-term L-arginine supplementation improves small-vessel coronary endothelial function in humans, Circulation 97 (1998) 2123-2128.
26. S.P. Schulman, L.C. Becker, D.A. Kass, et al., L-arginine therapy in acute myocardial infarction: the Vascular Interaction with Age in Myocardial Infarction (VINTAGE MI) randomized clinical trial, JAMA 295 (2006) 58-64.
27. M.J. Romero, D.H. Platt, R.B. Caldwell, et al., Therapeutic use of citrulline in cardiovascular disease, Cardiovasc. Drug Rev. 24 (2006) 275-290.
28. D. Susic, A. Francischetti, E.D. Frohlich, Prolonged L-arginine on cardiovascular mass and myocardial hemodynamics and collagen in aged spontaneously hypertensive rats and normal rats, Hypertension 33 (1999) 451-455.
29. S.M. Morris Jr., Regulation of enzymes of urea and arginine synthesis, Annu. Rev. Nutr. 12 (1992) 81-101.
30. M.J. Romero, D.H. Platt, H.E. Tawfik, et al., Diabetes-induced coronary vascular dysfunction involves increased arginase activity, Circ. Res. 102 (2008) 95-102.
31. H.M. El-Bassossy, R. El-Fawal, A. Fahmy, Arginase inhibition alleviates hypertension associated with diabetes: effect on endothelial dependent relaxation and NO production, Vascul. Pharmacol. 57 (2012) 194-200.
32. J.S. Pollock, U. Forstermann, J.A. Mitchell, et al., Purification and characterization of particulate endothelium-derived relaxing factor synthase from cultured and native bovine aortic endothelial cells, Proc. Natl. Acad. Sci. U.S.A. 88 (1991) 10480-10484.
33. T.A. Hardy, J.M. May, Coordinate regulation of L-arginine uptake and nitric oxide synthase activity in cultured endothelial cells, Free Radical Biol. Med. 32 (2002) 122-131.
34. S. Shin, S. Mohan, H.L. Fung, Intracellular L-arginine concentration does not determine NO production in endothelial cells: implications on the "L-arginine paradox", Biochem. Biophys. Res. Commun. 414 (2011) 660-663.
35. A. Simon, L. Plies, A. Habermeier, et al., Role of neutral amino acid transport and protein breakdown for substrate supply of nitric oxide synthase in human endothelial cells, Circ. Res. 93 (2003) 813-820.
36. R.A. Vogel, Coronary risk factors, endothelial function, and atherosclerosis: a review, Clin. Cardiol. 20 (1997) 426-432.